| 007 Comprehensive echocardiographic and cardiovascular magnetic resonance evaluation differentiates between patients with heart failure with preserved ejection fraction … I Mordi, S Singh, A Rudd, J Srivanasan, M Frenneaux, N Tzemos, ... Heart 103 (Suppl 1), A6-A7, 2017 | | 2017 |
| 044 A RANDOMISED CONTROLLED TRIAL OF DEFERRED STENTING VERSUS IMMEDIATE STENTING TO PREVENT NO-REFLOW IN ACUTE ST-ELEVATION MYOCARDIAL INFARCTION D Carrick, M McEntegart, C Haig, M Petrie, H Eteiba, S Hood, C Owens, ... Heart 99 (suppl 2), A31, 2013 | | 2013 |
| 11 Effect of pre-hospital administration of unfractionated heparin in acute st-elevation myocardial infarction C McGinley, I Mordi, P Kelly, P Currie, S Hutcheon, S Koch, T Martin, ... Heart 104 (Suppl 1), A6-A7, 2018 | | 2018 |
| 114 Persistence of Haemoglobin Degradation Products within Infarct Scar Tissue after ST-elevation Myocardial Infarction: Incidence, Correlates and Implications for Left … J Carberry, D Carrick, C Haig, S Rauhalammi, N Ahmed, I Mordi, ... Heart 102 (Suppl 6), A81-A81, 2016 | | 2016 |
| 115 Persistence of Infarct Zone Oedema at 6 Months after Acute ST-elevation Myocardial Infarction: Incidence, Pathophysiology and Association with Left Ventricular Remodelling J Carberry, D Carrick, C Haig, S Rauhalammi, N Ahmed, I Mordi, ... Heart 102 (Suppl 6), A81-A81, 2016 | | 2016 |
| 12 The influence of microvascular obstruction on the relationship between remote zone extracellular volume and subsequent left ventricular volumes in survivors of ST-elevation … J Carberry, D Carrick, C Haig, S Rauhalammi, N Ahmed, I Mordi, ... Heart 101 (Suppl 6), A4-A4, 2015 | | 2015 |
| 126 Urinary desmosine, a biomarker of elastin degradation is significantly elevated and associated with maximum aortic root size and aortic Z-scores in patients with bicuspid … Z Iskandar, J Huang, L Miller, C Chin, I Mordi, C Mcwilliam, D Goudie, ... Heart 105 (Suppl 6), A103-A104, 2019 | 2 | 2019 |
| 13 Natural history and clinical significance of infarct zone extracellular volume and remodelling in survivors of acute STEMI J Carberry, D Carrick, C Haig, S Rauhalammi, N Ahmed, I Mordi, ... Heart 101 (Suppl 6), A5-A5, 2015 | 1 | 2015 |
| 142 Insulin resistance, left ventricular hypertrophy and the impact of metformin use on cardiovascular outcomes in patients with calcific aortic stenosis: a genetic and … I Mordi, D Levin, A Aracil, M Mohan, J Singh, A Struthers, R Mccrimmon, ... European Heart Journal 39 (suppl_1), ehy564. 142, 2018 | | 2018 |
| 143 Integrating artificial intelligence into a real-world clinical pathway to facilitate clinician treatment optimisation in patients with hfref on suboptimal medical therapy ML Win, A Sinclair, K Georgiev, A Conkie, MS Hussain, CC Lang, ... Heart 110 (Suppl 3), A152-A153, 2024 | | 2024 |
| 2358 Metformin regresses left ventricular hypertrophy in normotensive patients with coronary artery disease without type 2 diabetes mellitus-The MET-REMODEL trialM M Mohan, S Al-Talabany, A McKinnie, I Mordi, JSS Singh, S Gandy, ... European Heart Journal 39 (suppl_1), ehy565. 2358, 2018 | | 2018 |
| 4 Extracellular volume in the infarct zone is associated with clinical and mri measures of infarct severity in survivors of acute stemi J Carberry, D Carrick, C Haig, SM Rauhalammi, N Ahmed, I Mordi, ... Heart 101 (Suppl 2), A2-A3, 2015 | | 2015 |
| 5 Relationships between infarct zone extracellular volume and clinical measures of ischaemia and reperfusion in acute STEMI survivors J Carberry, D Carrick, C Haig, SM Rauhalammi, N Ahmed, I Mordi, ... Heart 101 (Suppl 2), A3-A4, 2015 | | 2015 |
| 6 Metformin regresses left ventricular hypertrophy in normotensive patients with coronary artery disease without type 2 diabetes mellitus–the met-remodel trial M Mohan, S Al-Talabany, A McKinnie, I Mordi, J Singh, S Gandy, F Baig, ... Heart 104 (Suppl 6), A6-A6, 2018 | 14 | 2018 |
| 65 The novel plasma biomarker desmosine, a marker of elastin breakdown, is an independent predictor of abdominal aortic aneurysm events independent of aneurysm size I Mordi, R Forsythe, M Bown, C Lang, D Newby, C Gellatly, C Chin, ... Heart 104 (Suppl 6), A58-A59, 2018 | 1 | 2018 |
| 84 The prognostic significance of neutrophil to lymphocyte ratio in patients with heart failure with reduced and preserved ejection fraction F Curran, C Lang, C Palmer, I Mordi Heart 105 (Suppl 6), A71-A72, 2019 | | 2019 |
| A COMPREHENSIVE COMPARISON OF THE PATHOPHYSIOLOGICAL AND PROGNOSTIC SIGNIFICANCE OF CORONARY FLOW RESERVE AND THE INDEX OF MICROVASCULAR RESISTANCE IN THE CULPRIT CORONARY … D Carrick, C Haig, J Layland, N Ahmed, M McEntegart, M Petrie, H Eteiba, ... Journal of the American College of Cardiology 67 (13S), 383-383, 2016 | | 2016 |
| A randomised, placebo-controlled trial of the effects of IV serelaxin on myocardial blood flow and vascular function in patients with stable coronary artery disease (CAD) D Corcoran, A Radjenovic, I Mordi, S Nazir, S Wilson, ME Hinder, D Yates, ... EUROPEAN HEART JOURNAL 38, 510-511, 2017 | | 2017 |
| A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial M Mohan, S Al-Talabany, A McKinnie, IR Mordi, JSS Singh, SJ Gandy, ... European heart journal 40 (41), 3409-3417, 2019 | 122 | 2019 |
| A randomized trial of deferred stenting versus immediate stenting to prevent no-or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI) D Carrick, KG Oldroyd, M McEntegart, C Haig, MC Petrie, H Eteiba, ... Journal of the American College of Cardiology 63 (20), 2088-2098, 2014 | 303 | 2014 |
